中国卒中杂志 ›› 2023, Vol. 18 ›› Issue (02): 145-162.DOI: 10.3969/j.issn.1673-5765.2023.02.003
王昱懿, 赵威, 段婉莹, 杨中华, 刘丽萍
收稿日期:
2023-02-03
出版日期:
2023-02-20
发布日期:
2023-02-20
通讯作者:
刘丽萍 lipingsister@gmail.com
Received:
2023-02-03
Online:
2023-02-20
Published:
2023-02-20
王昱懿, 赵威, 段婉莹, 杨中华, 刘丽萍. 神经重症:回眸2022[J]. 中国卒中杂志, 2023, 18(02): 145-162.
WANG Yuyi, ZHAO Wei, DUAN Wanying, YANG Zhonghua, LIU Liping.
[1] LIU X F,DAI Q L,YE R D,et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion(BEST):an open-label,randomised controlled trial[J]. Lancet Neurol,2020,19(2):115-122. [2] LANGEZAAL LCM,VAN DER HOEVEN EJRJ,MONT’ALVERNE FJA,et al. Endovascular therapy for stroke due to basilar-artery occlusion[J]. N Engl J Med,2021,384(20):1910-1920. [3] JOVIN T G,LI C H,WU L F,et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion[J]. N Engl J Med,2022,387(15):1373-1384. [4] TAO C R,NOGUEIRA R G,ZHU Y Y,et al. Trial of endovascular treatment of acute basilar-artery occlusion[J]. N Engl J Med,2022,387(15):1361-1372. [5] SARRAJ A,GROTTA J C,PUJARA D K,et al. Triage imaging and outcome measures for large core stroke thrombectomy - a systematic review and meta-analysis[J]. J Neurointerv Surg,2020,12(12):1172-1179. [6] YOSHIMURA S,SAKAI N,YAMAGAMI H,et al. Endovascular therapy for acute stroke with a large ischemic region[J]. N Engl J Med,2022,386(14):1303-1313. [7] NIE X M,LENG X Y,MIAO Z R,et al. Clinically ineffective reperfusion after endovascular therapy in acute ischemic stroke[J]. Stroke,2023,54(3):873-881. [8] XIE Y,OPPENHEIM C,GUILLEMIN F,et al. Pretreatment lesional volume impacts clinical outcome and thrombectomy efficacy[J]. Ann Neurol,2018,83(1):178-185. [9] OSPEL J M,HILL M D,DEMCHUK A,et al. Clinical impact of EVT with failed reperfusion in patients with acute ischemic stroke:results from the ESCAPE and ESCAPE-NA1 trials[J]. Neuroradiology,2021,63(11):1883-1889. [10] POWERS W J,RABINSTEIN A A,ACKERSON T,et al. Guidelines for the early management of patients with acute ischemic stroke:2019 update to the 2018 guidelines for the early management of acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke,2019,50(12):e344-e418[2023-02-02]. https://doi.org/10.1161/STR.0000000000000211. [11] GUO Y J,LIN Y P,TANG Y F,et al. Safety and efficacy of early antiplatelet therapy in acute ischemic stroke patients receiving endovascular treatment:a systematic review and meta-analysis[J/OL]. J Clin Neurosci,2019,66:45-50[2023-02-02]. https://doi.org/10.1016/j.jocn.2019.05.028. [12] YANG M,HUO X C,GAO F,et al. Safety and efficacy of heparinization during mechanical thrombectomy in acute ischemic stroke[J/OL]. Front Neurol,2019,10:299[2023-02-02]. https://doi.org/10.3389/fneur.2019.00299. [13] BERGE E,WHITELEY W,AUDEBERT H,et al. European Stroke Organisation(ESO)guidelines on intravenous thrombolysis for acute ischaemic stroke[J]. Eur Stroke J,2021,6(1):1-62. [14] VAN DER STEEN W,VAN DE GRAAF R A,CHALOS V,et al. Safety and efficacy of aspirin,unfractionated heparin,both,or neither during endovascular stroke treatment(MR CLEAN-MED):an open-label,multicentre,randomised controlled trial[J]. Lancet,2022,399(10329):1059-1069. [15] ALMEKHLAFI M A,COUTTS S B. Anti-thrombotics cause harm in the setting of stroke thrombectomy[J]. Lancet,2022,399(10329):1025-1026. [16] CANNON C P,WEINTRAUB W S,DEMOPOULOS L A,et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Ⅱb/Ⅲa inhibitor tirofiban[J]. N Engl J Med,2001,344(25):1879-1887. [17] VAN'T HOF A W,TEN BERG J,HEESTERMANS T,et al. Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty(On-TIME 2):a multicentre,double-blind,randomised controlled trial[J]. Lancet,2008,372(9638):537-546. [18] CURA F A,BHATT D L,LINCOFF A M,et al. Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein Ⅱb/Ⅲa inhibition in complex atherosclerotic lesions[J]. Circulation,2000,102(1):28-34. [19] QIU Z M,LI F L,SANG H F,et al. Effect of intravenous tirofiban vs placebo before endovascular thrombectomy on functional outcomes in large vessel occlusion stroke:the RESCUE BT randomized clinical trial[J]. JAMA,2022,328(6):543-553. [20] MULDER M J H L,ERGEZEN S,LINGSMA H F,et al. Baseline blood pressure effect on the benefit and safety of intra-arterial treatment in MR CLEAN(Multicenter randomized clinical trial of endovascular treatment of acute ischemic stroke in the Netherlands)[J]. Stroke,2017,48(7):1869-1876. [21] YANG P F,SONG L L,ZHANG Y W,et al. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke(ENCHANTED2/MT):a multicentre,open-label,blinded-endpoint,randomised controlled trial[J]. Lancet,2022,400(10363):1585-1596. [22] CZOSNYKA M,SMIELEWSKI P,KIRKPATRICK P,et al. Continuous assessment of the cerebral vasomotor reactivity in head injury[J]. Neurosurgery,1997,41(1):11-19. [23] CARNEY N,TOTTEN A M,O'REILLY C,et al. Guidelines for the management of severe traumatic brain injury,fourth edition[J]. Neurosurgery,2017,80(1):6-15. [24] TAS J,BEQIRI E,VAN KAAM R C,et al. Targeting autoregulation-guided cerebral perfusion pressure after traumatic brain injury(COGiTATE):a feasibility randomized controlled clinical trial[J]. J Neurotrauma,2021,38(20):2790-2800. [25] SANDRONI C,CRONBERG T,SEKHON M. Brain injury after cardiac arrest:pathophysiology,treatment,and prognosis[J]. Intensive Care Med,2021,47(12):1393-1414. [26] RUIJTER B J,KEIJZER H M,TJEPKEMA-CLOOSTERMANS M C,et al. Treating rhythmic and periodic EEG patterns in comatose survivors of cardiac arrest[J]. N Engl J Med,2022,386(8):724-734. [27] KJAERGAARD J,SCHMIDT H,MØLLER J E,et al. The "blood pressure and oxygenation targets in post resuscitation care,a randomized clinical trial":design and statistical analysis plan[J]. Trials,2022,23(1):177. [28] KJAERGAARD J,MØLLER J E,SCHMIDT H,et al. Blood-pressure targets in comatose survivors of cardiac arrest[J]. N Engl J Med,2022,387(16):1456-1466. [29] SCHMIDT H,KJAERGAARD J,HASSAGER C,et al. Oxygen targets in comatose survivors of cardiac arrest[J]. N Engl J Med,2022,387(16):1467-1476. [30] ZHAO J J,YUAN F,SONG C G,et al.Safety and efficacy of three enteral feeding strategies in patients with severe stroke in China(OPENS):a multicentre,prospective,randomised,open-label,blinded-endpoint trial[J]. Lancet Neurol,2022,21(4):319-328. [31] BÖSEL J,SCHILLER P,HOOK Y,et al. Stroke-related early tracheostomy versus prolonged orotracheal intubation in neurocritical care trial(SETPOINT):a randomized pilot trial[J]. Stroke,2013,44(1):21-28. [32] BÖSEL J,NIESEN W D,SALIH F,et al.Effect of early vs standard approach to tracheostomy on functional outcome at 6 months among patients with severe stroke receiving mechanical ventilation:the SETPOINT2 randomized clinical trial[J]. JAMA,2022,327(19):1899-1909. [33] HORN C M,SUN C H,NOGUEIRA R G,et al. Endovascular reperfusion and cooling in cerebral acute ischemia(ReCCLAIM I)[J]. J Neurointerv Surg,2014,6(2):91-95. [34] LYDEN P,HEMMEN T,GROTTA J,et al. Results of the ICTuS 2 trial(intravascular cooling in the treatment of stroke 2)[J]. Stroke,2016,47(12):2888-2895. [35] LEVY B,GIRERD N,AMOUR J,et al. Effect of moderate hypothermia vs normothermia on 30-day mortality in patients with cardiogenic shock receiving venoarterial extracorporeal membrane oxygenation:a randomized clinical trial[J]. JAMA,2022,327(5):442-453. |
[1] | 周宏宇, 李子孝. 数字生物标志物:打开数智医疗应用的钥匙[J]. 中国卒中杂志, 2025, 20(4): 385-390. |
[2] | 张栗源, 刘涛, 姜勇, 李子孝, 王拥军, 杨晓萌. 基于脑影像及临床特征的机器学习模型预测缺血性卒中后心房颤动[J]. 中国卒中杂志, 2025, 20(4): 392-400. |
[3] | 程相鑫, 张烁, 杜松骏, 刘子阳, 周宏宇, 贾伟丽, 李子孝, 刘涛. 基于IMU信号的人工智能上肢多关节运动状态识别系统构建——卒中后人工智能运动功能评估与检测系统建设前导研究[J]. 中国卒中杂志, 2025, 20(4): 401-409. |
[4] | 蒲善宇, 潘岳松, 王拥军. 基于无监督学习识别吲哚布芬治疗急性中重度缺血性卒中的应答患者[J]. 中国卒中杂志, 2025, 20(4): 410-417. |
[5] | 蒋兰, 傅新民, 孙梦飞, 李怡萍. 大脑中动脉闭塞性急性缺血性卒中血管内治疗后不良预后的危险因素分析及预测模型开发[J]. 中国卒中杂志, 2025, 20(4): 418-427. |
[6] | 倪佃丽, 陈晓兵, 张广慧, 彭庆荣. 急性缺血性卒中院前延迟风险预测模型的构建及评价[J]. 中国卒中杂志, 2025, 20(4): 428-434. |
[7] | 张欣悦, 常红, 赵洁, 李佩佩, 刘梦娆, 李苏爱. 急性缺血性卒中患者运动想象训练中认知负荷与生理指标的相关性研究[J]. 中国卒中杂志, 2025, 20(4): 435-446. |
[8] | 张永庆, 李娜, 高伊丽, 秦佳文, 俞海萍, 赵婷婷. 1990—2021年中国归因于高LDL-C的卒中死亡负担变化趋势及预测分析[J]. 中国卒中杂志, 2025, 20(4): 447-456. |
[9] | 王岩, 郝怀宇, 陆强, 张蕾, 沈学延, 魏桂梅. 细胞外水分比率对急性缺血性卒中患者出院结局的影响[J]. 中国卒中杂志, 2025, 20(4): 457-461. |
[10] | 胡燕琴, 赵陶丽, 李申, 郭东兴, 赵志刚. 静脉应用银杏叶制剂治疗急性缺血性卒中有效性和安全性的meta分析[J]. 中国卒中杂志, 2025, 20(4): 462-469. |
[11] | 赵乾坤, 李宪东, 徐天策, 陈会生. 基于脑-肠轴探讨针灸治疗缺血性卒中机制的基础研究进展[J]. 中国卒中杂志, 2025, 20(4): 486-492. |
[12] | 池琦, 赵颖, 韩东倩, 张锶琪, 杜沛洁, 董琬玥, 徐安定, 杨振国, 孟珩. 急性缺血性卒中发病时间评估的研究进展[J]. 中国卒中杂志, 2025, 20(4): 493-499. |
[13] | 赵开杰, 孙秀亭, 袁曼, 胡婉贞, 张晓燕. 脑侧支循环评估方法的研究进展[J]. 中国卒中杂志, 2025, 20(4): 500-510. |
[14] | 郭园丽, 高任轲, 杨彩侠, 范文凤, 郭丽娜, 董小方, 吕培华, 高欢欢, 马珂珂. 急性缺血性卒中静脉溶栓意向量表的编制及信效度检验[J]. 中国卒中杂志, 2025, 20(4): 511-518. |
[15] | 樊燕琴, 曹黎明, 任力杰. 我国社区卒中防治:医防融合视角下的卒中防治现状、挑战与策略分析[J]. 中国卒中杂志, 2025, 20(3): 261-268. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||